Intercept Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | -$1.77 | -$1.19 | -$1.48 |
Intercept Pharmaceuticals, Inc. Earnings Date And Information
Intercept Pharmaceuticals, Inc. last posted its earnings results on Tuesday, November 7th, 2023. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.2. The company had revenue of 88.79 M for the quarter and had revenue of 285.71 M for the year. Intercept Pharmaceuticals, Inc. has generated $3 earnings per share over the last year ($3.4 diluted earnings per share) and currently has a price-to-earnings ratio of -91.78. Intercept Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based on prior year's report dates.
Intercept Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2023 | Q3 2023 | -$0.07 | $88.02 M | $88.79 M | ||
| 08/02/2023 | Q2 2023 | -$0.56 | -$0.14 | 0.42 | $79.57 M | $83.72 M |
| 04/27/2023 | Q1 2023 | -$0.57 | -$0.71 | -0.14 | $67.96 M | |
| 03/02/2023 | Q4 2022 | -$0.53 | -$0.49 | 0.04 | $77.22 M | |
| 11/01/2022 | Q3 2022 | $5.11 | $5.07 | -0.04 | $89.99 M | $77.59 M |
| 08/03/2022 | Q2 2022 | -$0.53 | -$0.25 | 0.28 | $95.72 M | $71.76 M |
| 05/06/2022 | Q1 2022 | -$0.89 | -$0.58 | 0.31 | $88.58 M | |
| 03/02/2022 | Q4 2021 | -$1.26 | -$1.23 | 0.03 | $92.40 M | |
| 11/03/2021 | Q3 2021 | -$1.00 | -$0.11 | 0.89 | $81.81 M | $92.83 M |
| 07/29/2021 | Q2 2021 | -$1.24 | -$0.33 | 0.91 | $82.68 M | $96.58 M |
| 05/06/2021 | Q1 2021 | -$1.53 | -$1.22 | 0.31 | $81.66 M | |
| 02/25/2021 | Q4 2020 | -$1.55 | -$1.58 | -0.03 | $83.27 M | |
| 11/09/2020 | Q3 2020 | -$1.96 | -$2.01 | -0.05 | $76.22 M | $79.52 M |
| 08/10/2020 | Q2 2020 | -$2.94 | -$1.92 | 1.02 | $117.48 M | $77.25 M |
| 05/11/2020 | Q1 2020 | -$2.94 | -$2.86 | 0.08 | $72.65 M | |
| 02/25/2020 | Q4 2019 | -$2.56 | -$2.99 | -0.43 | $71.50 M | |
| 11/05/2019 | Q3 2019 | -$2.35 | -$2.59 | -0.24 | $58.12 M | $61.95 M |
| 08/08/2019 | Q2 2019 | -$2.28 | $75.61 M | $66.30 M | ||
| 05/08/2019 | Q1 2019 | -$2.57 | -$3.03 | -0.46 | $52.25 M | |
| 03/01/2019 | Q4 2018 | -$2.97 | $53.28 M |
Intercept Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Intercept Pharmaceuticals, Inc.'s earnings date?
Intercept Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 5th, 2023 based off last year's report dates.
-
Did Intercept Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Intercept Pharmaceuticals, Inc. (:ICPT) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.2.
-
How can I listen to Intercept Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Intercept Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Intercept Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Intercept Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Intercept Pharmaceuticals, Inc. generate each year?
Intercept Pharmaceuticals, Inc. (:ICPT) has a recorded annual revenue of $285.71 M.
-
How much profit does Intercept Pharmaceuticals, Inc. generate each year?
Intercept Pharmaceuticals, Inc. (:ICPT) has a recorded net income of $285.71 M. Intercept Pharmaceuticals, Inc. has generated $3.41 earnings per share over the last four quarters.
-
What is Intercept Pharmaceuticals, Inc.'s price-to-earnings ratio?
Intercept Pharmaceuticals, Inc. (:ICPT) has a price-to-earnings ratio of -91.78 and price/earnings-to-growth ratio is 0.67.
